CCCC peer analysis
C4 Therapeutics (CCCC) against its competitors: price, today's move, 1-year return and market value side by side.
CCCC and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARMP Armata Pharmaceuticals | $3.00 | -4.46% | -35.12% | $116.75M |
| CDXS Codexis | $1.02 | -5.56% | -50.23% | $118.27M |
| IMDX Insight Molecular Diagnostics | $2.46 | -7.17% | -56.77% | – |
| MIST Milestone Pharmaceuticals | $0.69 | -10.36% | -58.02% | $96.17M |
| MOLN Molecular Partners | $3.21 | -0.98% | – | – |
| OABI OmniAb | $5.02 | 3.93% | 226.35% | – |
| PEPG PepGen | $2.50 | 7.68% | -49.45% | – |
| CCCC C4 Therapeutics | $3.14 | 6.44% | 30.75% | – |
- CCCC's peers: ARMP (Armata Pharmaceuticals), CDXS (Codexis), IMDX (Insight Molecular Diagnostics), MIST (Milestone Pharmaceuticals), MOLN (Molecular Partners), OABI (OmniAb), PEPG (PepGen).
Updated 2026-11-07 11:54 UTC